Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes ...

A key clause in Microsoft and OpenAI's deal embodies the raging divide between AGI true believers and those who think it's ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya Nade ...

Microsoft AI savings are making headlines as the company reveals it saved over $500 million using AI tools across sales, ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

After laying off 9000 workers, Microsoft touts itself as saving $500 million in AI efficiency.

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...